Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 211-776-7 | CAS number: 694-83-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Study period:
- From 05 OCT 1988 to 23 NOV 1988
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Basic data given: comparable to guidelines/standards
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
- Principles of method if other than guideline:
- Skin sensitisation test in guinea pigs. Primary irritation phase (1 drop open epikutan). Two days thereafter followed by induction phase (4 intradermal injections with 0.1 ml of 1% (v/v) emulsion, 1 injection per week). Challenge treatment (open epicutan) of animals was done two weeks after last induction injection. Rechallenge was performed in the same way as challenge procedure but one week thereafter.
- GLP compliance:
- yes
- Remarks:
- according to US EPA regulations
- Type of study:
- intracutaneous test
Test material
- Reference substance name:
- Cyclohex-1,2-ylenediamine
- EC Number:
- 211-776-7
- EC Name:
- Cyclohex-1,2-ylenediamine
- Cas Number:
- 694-83-7
- Molecular formula:
- C6H14N2
- IUPAC Name:
- cyclohexane-1,2-diamine
- Details on test material:
- - Name of test material (as cited in study report): 1,2-cyclohexanediamine (DCH)
- Substance type: colourless liquid
- Physical state: fluid
- Analytical purity: 89 %
- Impurities (identity, but no quantities mentioned):
hexamethylenediamine
hexamethyleneimine
2-methylpentamethylenediamine
2-(aminomethyl)cyclopentylamine
- Stability under test conditions: the test material was assumed to be stable under the conditions of administration
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male/female
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal
- Vehicle:
- other: epicutaneous applications: water; intradermal injections: physiological saline
- Concentration / amount:
- primary irritation: 1 drop of 1 or 10 % emulsion of test substance in distilled water (vehicle control group treated with water)
sensitisation: 4 sacral intradermal injections (1 each week) of 0.1 mL of a 1.0 % (v/v) emulsion of test substance (vehicle control group treated with physiological saline)
challenge: 1 drop of 1 or 10 % emulsion of test substance in distilled water (vehicle control group treated with water, negative control animals also treated)
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: epicutaneous applications: water; intradermal injections: physiological saline
- Concentration / amount:
- primary irritation: 1 drop of 1 or 10 % emulsion of test substance in distilled water (vehicle control group treated with water)
sensitisation: 4 sacral intradermal injections (1 each week) of 0.1 mL of a 1.0 % (v/v) emulsion of test substance (vehicle control group treated with physiological saline)
challenge: 1 drop of 1 or 10 % emulsion of test substance in distilled water (vehicle control group treated with water, negative control animals also treated)
- No. of animals per dose:
- 10 animals (5 males, 5 females) in the test dose group,
5 vehicle control animals (3 males , 2 females),
10 positive control animals (5 males, 5 females)
2x5 animals (in each group 2 males, 3 females) in negative control group (one group received at challenge test material the other group positive control substance). - Positive control substance(s):
- yes
- Remarks:
- p-phenylenediamine
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 8
- Total no. in group:
- 9
- Clinical observations:
- 4/9 animals showed slight erythema, 1/9 mild erythema and 3/9 moderate erythema, 1 animal died during induction phase.
- Remarks on result:
- other: clincal observation: 4/9 animals showed slight erythema, 1/9 mild erythema and 3/9 moderate erythema, 1 animal died during induction phase.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 10%
- No. with + reactions:
- 8
- Total no. in group:
- 9
- Clinical observations:
- 4/9 animals showed slight erythema, 1/9 mild erythema and 3/9 moderate erythema, 1 animal died during induction phase.
- Remarks on result:
- other: Clinical observations: 4/9 animals showed slight erythema, 1/9 mild erythema and 3/9 moderate erythema, 1 animal died during induction phase.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- 1 animal died during induction phase
- Remarks on result:
- other: Clinical observations: 1 animal died during induction phase.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 1%
- No. with + reactions:
- 0
- Total no. in group:
- 9
- Clinical observations:
- 1 animal died during induction phase
- Remarks on result:
- other: Clinical observations: 1 animal died during induction phase.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 10%
- No. with + reactions:
- 3
- Total no. in group:
- 5
- Clinical observations:
- slight erythema observed
- Remarks on result:
- other: Clinical observation: slight erythema observed
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 10 %
- No. with + reactions:
- 3
- Total no. in group:
- 5
- Clinical observations:
- slight erythema observed
- Remarks on result:
- other: Clinical observation: slight erythema observed
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 1 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- other: vehicle control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- other: vehicle control
- Dose level:
- 0
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 30% p-phenylenediamine
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- 2/10 animals showed slight erythema, 6/10 mild erythema and 1/10 moderate erythema
- Remarks on result:
- other: Clinical observations: 2/10 animals showed slight erythema, 6/10 mild erythema and 1/10 moderate erythema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 30% p-phenylenediamine
- No. with + reactions:
- 9
- Total no. in group:
- 10
- Clinical observations:
- 4/10 animals showed slight erythema, 4/10 mild erythema and 1/10 moderate erythema, 2 animals showed oedema
- Remarks on result:
- other: Clinical observations: 4/10 animals showed slight erythema, 4/10 mild erythema and 1/10 moderate erythema, 2 animals showed oedema
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 3 % p-phenylenediamine
- No. with + reactions:
- 6
- Total no. in group:
- 10
- Clinical observations:
- 5/10 animals showed slight erythema, 1/10 mild erythema
- Remarks on result:
- other: Clinical observations: 5/10 animals showed slight erythema, 1/10 mild erythema
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 3 % p-phenylenediamine
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Clinical observations:
- 3/10 animals showed slight erythema, 1/10 mild erythema
- Remarks on result:
- other: Clinical observations: 3/10 animals showed slight erythema, 1/10 mild erythema
Any other information on results incl. tables
Rechallenge (one week after the challenge) under the same conditions as the challenge resulted in comparable results. Body weight gain was normal in all animals.
erythema scores:
0: no erythema
1: slight erythema
2: mild erythema
3: moderate erythema
4: severe erythema
Applicant's summary and conclusion
- Interpretation of results:
- other: ambiguous, according to authors: mild dermal sensitiser
- Conclusions:
- Under the applied test conditions, results of this skin sensitisation assay with guiunea pigs are ambiguous, as corrosiveness of the substance complicated interpretation of results. A rechallenge exposure therfore was needed. According to the study authors the test substance reveals weak skin sensitising effects taken the results from the rechallenge exposure.
- Executive summary:
In an intracutaneous guinea pig test 5 male and 5 female guinea pigs were treated with two concentrations of test substance each (10 % or 1 % of test material; i.e. Primary irritation phase (1 drop open epikutan). Two days thereafter followed by induction phase (4 intradermal injections with 0.1 ml of 1% (v/v) emulsion, 1 injection per week). Additional animals were used as negative and positive control animals. After challenge (open epicutaneous, was done two weeks after last induction injection) with the test substance animals in the 10 % group showed very slight to moderate erythema in the 24 and 48 h reading (8/9 and 8/9 animals). In the corresponding negative control group 3/5 animals showed slight erythema in the 24 and 48 h reading, revealing the irritant potential of the test substance at this concentration level. In the 1 % test group no effects were observed. Due to this observed results rechallenge was performed in the same way as challenge procedure but one week thereafter. 48 hours after rechallenge with 10% of test material 6/9 animals showed slight or mild erythema, whereas none of the negative control animals showed skin response. In the 1 % test group and negative control group no effects were observed.
Under the applied test conditions, results of this skin sensitisation assay with guinea pigs are ambiguous, as corrosiveness of the substance complicated interpretation of results. A rechallenge exposure therefore was needed. According to the study authors the test substance reveals weak skin sensitising effects taken the results from the rechallenge exposure.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.